Telemedicine for international travelers through a Smartphone-based monitoring platform (Trip Doctor®)

Overall, more than 50% of international travelers develop symptoms while traveling and 55% of them seek medical assistance during the trip. We conducted a study to evaluate the usefulness of a Smartphone app called TRIP Doctor® to provide telemedicine to international travelers. Participants over 18...

Full description

Saved in:
Bibliographic Details
Published in:Travel medicine and infectious disease 2022-09, Vol.49, p.102356-102356, Article 102356
Main Authors: Rodriguez-Valero, N., Carbayo, MJ Ledesma, Camprubí-Ferrer, D., Martí-Soler, H., Sanchez, D. Cuadrado, Vladimirov, A., Pinazo, M.J., Almuedo-Riera, A., Roman, A., Vera, I., Roldan, M., de Alba, T., Jimenez, A., Gómez-Valverde, Juan J., Oroz, M Luengo, Muñoz, J.
Format: Article
Language:English
Subjects:
Diarrhea
Digital participatory surveillance system
Disease prevention
Fever
Histamine
Hospitals
Infectious diseases
Malaria
Medical apps
Medical personnel
Multivariate analysis
Population
Real-time health recordings
Smartphone
Smartphones
Symptoms
Telehealth
Telemedicine
Thrombosis
Travel
Travel medicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Overall, more than 50% of international travelers develop symptoms while traveling and 55% of them seek medical assistance during the trip. We conducted a study to evaluate the usefulness of a Smartphone app called TRIP Doctor® to provide telemedicine to international travelers. Participants over 18 years old attending our travel clinic at Hospital Clinic in Barcelona were invited to participate during 2017–2019. After downloading the app, the health status of the traveler was monitored on a daily basis, providing specific medical advice and offering remote contact with specialized physicians through an integrated chat, if needed. From 449 users, 59 (13%) contacted for medical assistance through the app during the trip. Main reasons for telemedicine were diarrhea (25.7%), skin conditions (19.7%) and fever (12.1%). Among patients who contacted, 90% of the travelers did not require to be referred to a local doctor. Symptomatic treatment was the main treatment prescribed (38%). In a 14.7% of the cases a follow-up was not required, a 63.2% recovered and 22.1% were loss of follow-up. After a multivariate analysis, duration of trip >14 days was found to be the only factor associated with the use of telemedicine (OR 2.2, CI 95% 1.1–4.5, p = 0.03). In conclusion, travelers using telemedicine travelled for longer periods of time and mostly contacted for mild symptoms which could be solved successfully by remote assistance with our specialized doctors.
ISSN:1477-8939
1873-0442
DOI:10.1016/j.tmaid.2022.102356